Complement component C8 alpha chain
| GO Term |
|---|
| extracellular region |
| extracellular space |
| plasma membrane |
| membrane attack complex |
| membrane |
| extracellular exosome |
| blood microparticle |
| GO Term |
|---|
| complement binding |
| protein-containing complex binding |
| Position | Description |
|---|---|
| 43 | Not glycosylated |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 33 |
|
|
||
| 43 |
|
|||
| 44 | C-linked (Man) tryptophan |
|
||
| 437 | N-linked (GlcNAc...) asparagine | |||
| 542 | C-linked (Man) tryptophan |
|
||
| 545 | C-linked (Man) tryptophan |
|
||
| 548 | C-linked (Man) tryptophan |
|
| Pathway Name | Organism |
|---|---|
| Regulation of Complement cascade | Homo sapiens |
| Terminal pathway of complement | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060301 | type I complement component 8 deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025